Biederman Motech GmbH – Trademark Portfolio

Entity Type: 11

Biederman Motech GmbH holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MOSS-MAX. The owner is based in 78054 VS-Schwenningen.

Berta-Suttner-Strasse 23

78054 VS-Schwenningen , DE

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MOSS-MAX
MOSS-MAX
Registered 2001

Trademark Classifications

Biederman Motech GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Biederman Motech GmbH have?

Biederman Motech GmbH has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Biederman Motech GmbH file in?

Biederman Motech GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Biederman Motech GmbH's most well-known trademarks?

Biederman Motech GmbH's registered trademark portfolio includes well-known marks such as MOSS-MAX. These are among 1 currently registered trademark in the portfolio.

What is Biederman Motech GmbH's trademark registration success rate?

Biederman Motech GmbH has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.